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1. Introduction 
The synthesis of encephalomyocarditis (EMC)virus 
proteins, like proteins of other picornaviruses, is initi- 
ated at a site located in the 5’-adjacent region of the 
viral genome; the product of this synthesis is repre- 
sented by a giant polypeptide chain, polyprotein, 
which contains all the amino acid sequences present 
in the structural and non-structural viral proteins; the 
final products of translation, ‘mature’ proteins, are 
generated by sequential proteolytic cleavages of the 
polyprotein molecule starting while the latter is in the 
nascent form [I]. Using a variety of techniques, cleav- 
age maps of the EMC virus polyprotein were con- 
structed, which showed the order of different poly- 
peptide chains relative to the N-terminus of the poly- 
protein molecule [ 11. Most of the details of these 
maps are now generally accepted, but some points 
remain unclear or disputable. One of these important 
points concerns the uppermost N-terminal region of 
the polyprotein: which particular polypeptide is the 
first to be translated? The usually considered candi- 
date is the precursor of capsid proteins, polypeptide A, 
which is assumed to share the N-terminal amino acid 
sequence with its cleavage products, polypeptides B 
and Dl . This view was supported by the finding that, 
upon in vitro translation of EMC virus RNA, formyl- 
[35S]Met-tRNAyet could donate a labelled formyl- 
methionyl residue to the polypeptides (by inference, 
to their N-terminal position) that comigrated with 
polypeptides A, B and possibly, Dl [2]. On the other 
hand, earlier data obtained with the same labelled sub- 
strate but using less efficient cell-free translation sys- 
terns suggested that formyl-methionine might be 
incorporated in peptides other than those correspond- 
ing to the capsid proteins [3-51. 
We have attempted to solve the controversy and 
show here that: 
(i) The initiator amino acid sequences, as defined by 
the presence of formyl-methionyl residue, are 
contained in a precursor polypeptide, preA; 
(ii) Upon a short treatment of preA with a prepara- 
tion of EMC virus-specific protease [6], these ini- 
tiator sequences are cleaved off and emerge in 
two low-M, closely-related polypeptides, p14 and 
p12; 
(iii) After the removal of p 14 (p 12) the remaining 
moiety of preA corresponds to the precursor of 
capsid proteins, polypeptide A; 
(iv) preA, p 14 and p 12 appear to share an N-terminal 
amino acid sequence. 
These data suggest hat all 3 latter polypeptides are 
initiated at a common single site on the viral genome 
and that p14 (p 12) should occupy the N-terminal 
position on the EMC virus polyprotein cleavage map 
followed by polypeptide A, a precursor of the capsid 
proteins. 
2. Methods 
2.1. Label&g viral polypeptides in vivo and in vitro 
Address reprint requests to V. I. A. 
Suspensions of ascites carcinoma Krebs-II cells 
were prepared and infected with EMC virus as in [7]. 
[ 35S]Methionine (50 @X/ml; Amersham) was added 
at 3.5 h postinfection, and after a 60 min additional 
incubation the cells were lysed in a buffer containing 
SDS and urea [8]. 
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Translation of EMC virus RNA in a micrococcal 
nuclease-treated extracts of Krebs-II cells was done as 
in [8,9]. Preparation of formyl-[35S]Met-tRNA~ef 
was described in [lo]. 
2.2. Electrophoresis in polyacrylamide gels 
Electrophoretic separation of labelled polypeptides 
was performed using SDS-containing gradient (8-20%) 
polyacrylamide slabs and a discontinuous buffer sys- 
tem [ 1 l] followed by autoradiography. 
2.3. Isolation and fingerprin ting of tryptic / 35S]methi- 
onine-containing peptides 
Regions containing labelled viral polypeptides were 
excised from polyacrylamide slabs, the excised gels 
were washed with methanol and HzO, digested with 
TPCK-treated trypsin (300 pg/ml; 40 U/mg; Serva) 
for 16 h at 37’C, and peptides were eluted from the 
gels as in [ 121. The eluates were lyophilized twice, 
dissolved in a mixture containing 15% acetic acid and 
5% formic acid, applied onto 10 X 10 cm thin-layer 
cellulose plates (Merck) and electrophoresed for 
30 min at 500 V. The second-dimension ascending 
chromatography was carried out in a buffer containing 
butanol:pyridine:acetic acid:H,O (32.5:25:5:20, 
by vol.) with 7% (w/v) 2,5-diphenyloxazole [ 131. The 
dried plates were fluorographed at -7O’C. 
2.4. Isolation and analysis of tryp tic formyl-[ 35S]- 
methionine-containing peptides 
Products of in vitro translation of EMC virus RNA 
in the presence of formyl-[ 35S]Met-tRNAyet (either 
unfractionated or eluted from the gel as individual 
polypeptides, preA, p14 and p 12) were oxidized with 
performic acid, digested with TPCK-treated trypsin, 
and analyzed by high-voltage paper electrophoresis at 
pH 10.2 [14]. 
3. Results and discussion 
Prolonged translation of EMC virus RNA in the 
Krebs-II-derived cell-free system using [ 35S]methio- 
nine as labelled substrate results in accumulation of a 
nearly full complement of virus-specific polypeptides 
found in the virus-infected cells as well as of some 
additional species (fig.1, lane 1; cf. [8,9]). On the 
other hand, if formyl-[35S]Met-tRNA~f is used as 
the labelled substrate, only 3 major radioactive spe- 
cies can be revealed (fig.1, lane 2); these are polypep- 
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Fig.1. Electrophoretic patterns of the products of in vitro 
translation of EMC virus RNA. [ Y3 JMethionine (lanes 1,5,6) 
or formyl-[ %]Met-tRNApt (lanes 2-4) were used as label- 
led substrates. Samples 1,2 were incubated for 150 min at 
30°C. Samples 3-6 were incubated for 30 min at 3O”C, then 
the synthesis was stopped by the addition of cycloheximide 
to 250 fig/ml final cont.; simultaneously acytoplasmic extract 
(S,, fraction) from EMC virus-infected cells was added 
(0.1 vol. of the sample) to samples 4,6. After the addition of 
cycloheximide, samples 3-6 were incubated for 5 min at 37°C. 
tides preA, p14, and p12 (of -112 000,14 000 and 
12 000 Mr, respectively). Neither of the 3 is present 
in any significant amount in the virus-infected cells 
(cf. [ 151). Trace formyl-methionine radioactivity 
may also be incorporated in vitro into polypeptides 
comigrating with proteins A and (sometimes) B. Thus, 
the labelling of high&r polypeptides with formyl- 
methionine in our system is virtually similar to that 
observed in a reticulocyte-derived one [2], but in the 
latter no incorporation of this residue in polypeptides 
analogous to p14 and p12 was observed. 
The presence of formyl-methionine in the 3 in vitro 
products might be explained by their independent ini- 
tiation. Alternatively, the smaller species might repre- 
sent cleavage products of the larger molecule. The fol- 
lowing experiment proved that the latter possibility 
was correct. Cell-free samples programmed with EMC 
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virus RNA were incubated with either [ 35S]methio- 
nine or formyl-[ 35S]Met-tRNAp for a relatively 
short time interval to allow significant synthesis of 
only precursors of capsid proteins (fig.1, lanes 3,5). 
Virus-specific protease, which is encoded farther 
toward the 3’-end of the genome [9,16], could not be 
formed in appreciable amounts during this period, 
and this was shown by the absence of any methionine- 
containing mature capsid proteins. Significantly, p14 
and p12 were also absent, regardless of the substrate 
used. Further translation was stopped by cyclohexim- 
ide, and an extract from the virus-infected cells was 
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added as a source of viral protease. After an incuba- 
tion as short as 5 min, prominent formyl-methionine- 
and methionine-labelled bands in the p 14 and p 12 
regions appeared (fig.1, lanes 4,6) concomitantly with 
the partial loss of radioactivity from the highfir pre- 
cursor. As expected, protease also promoted the 
appearance of methionine-labelled mature capsid pro- 
teins (fig.1, lane 6). 
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The conclusion that p 14 and p 12 are derived from 
preA was further supported by the fact that [ 35S]- 
methionine-labelled tryptic peptides of the two former 
species appeared to be (closely related to one another) 
subsets of tryptic peptides of the latter (fig.2). The 
patterns of non-p14 (~12) tryptic peptides of preA, 
on the one hand, and of polypeptide A synthesized 
either in vitro or in vivo, on the other, were nearly 
identical to each other. 
These data establish that in the preA molecule (and 
by inference, in the EMC virus polyprotein molecule), 
the amino acid sequence of polypeptide A, a precursor 
of capsid proteins, is preceded by sequences corre- 
sponding to non-structural polypeptides p14 and ~12. 
Fig.2. Tryptic peptide maps of the in vitro synthesized poly- 
peptides preA, A, p14 and p12 as well as of the in vivo syn- 
thesized polypeptide A. On the scheme, white spots represent 
peptides derived from ~14 and ~12, black spots correspond 
to the non-p14(p12) peptides of preA. 
This conclusion seems to contradict the apparent 
labelling of polypeptide A with formyl-methionine 
observed here (fig.1, lane 2,3) and in [2]. The contro- 
versy may easily be explained, however, if we assume 
that the labelled polypeptide comigrating with A is 
not an authentic A but rather an unfinished preA (A 
and unfinished preA lack a N-terminal and a C-termi- 
nal portion of preA, respectively). 
The function, if any, of the picornaviral leader 
polypeptides remains unknown, but our impression is 
that they are in many respects similar to signal poly- 
peptides of some membrane-reacting proteins [20]. 
Judging by the failure of the infected cells to accumu- 
late appreciable amounts of the leader polypeptides, 
they are unstable, rapidly turning-over products. This 
inference is also supported by some in vitro observa- 
tions [ 1.51. 
The presence of coding sequences that precede the While elucidating the gross relative location of the 
first capsid protein gene does not appear to be a com- coding sequences in the 5’-terminal region of the EMC 
mon feature of all picornavirus genomes. While leader virus genome, the above findings pose another impor- 
polypeptides similar to those described here were also tant problem: What is the difference between the 
reported for foot-and-mouth disease virus [ 171, they closely related polypeptides p 14 and p 12, both of 
have been neither found among the product of in vitro which could be labelled with formyl-methionine? If 
translation nor deduced from the primary structure the smaller polypeptide is devoid of a N-terminal por- 
of the genome [ 18,191 in the case of poliovirus. tion of the larger one, this would signify the existence 
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Fig.3. Electrophoretic patterns of the formyl-methionine- 
labelled tryptic peptides derived from the products of in vitro 
translation of EMC virus RNA. Paper electrophoresis was 
carried out at pH 10.2 at 2.2 kV for 120 min. Peptides derived 
from the total invitro product (a), from p14 (b) and from pl2 
(c). The position of formyl-methionine is indicated by arrows. 
of two different sites for initiation of translation. If, 
on the other hand, the difference between the two 
polypeptides resides in their C-termini, alternative 
cleavage sites should be invoked. 
The formyl-methionine-labelled tryptic peptides of 
the preA-containing total in vitro product, p14 and 
pl2 appear to be represented by the same single major 
species when electrophoresed at pH 10.2 (fig.3). This 
suggests that the N-terminal amino acid sequences of 
all 3 proteins are identical. However, trypsinolysis of 
formyl-methionine-containing proteins, regardless of 
their nature, sometimes gives rise to more than one 
major labelled products. Several lines of evidence sug- 
gested that these additional products were, most 
likely, of artifactual origin (unpublished). 
Thus, a single major initiation site appears to be 
utilized for the synthesis of both leader polypeptides, 
p14 and ~12, as well as of preA. Some circumstantial 
evidence suggests that p 14 is not a precursor to p 12; 
rather, both polypeptides are produced by alternative 
cleavages of preA. If this suggestion is correct, the 
questions concerning the heterogeneity of the N-ter- 
minal sequence of the capsid protein precursor, poly- 
peptide A, and the possible correction of this hetero- 
geneity, arise. Further experiments are required to 
answer these questions. 
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